After undergoing successful surgery for a dilated aorta on May 13, Eli Lilly Chairman, President, and CEO John Lechleiter has received medical clearance to return to his duties, the company announced today.
With Lechleiter's return, Derica Rice will revert to his former role as executive vice president, global services and CFO, after serving as Lilly's interim CEO, the company said. Lechleiter commented, "I want to thank and acknowledge Derica Rice for the important role he played during my absence, as well as Ellen Marram for her leadership of the Lilly board."
Lechleiter first joined Lilly in 1979 as a senior organic chemist in England, taking over the process research and development department in 1982. Lechleiter continually rose through the ranks of Lilly's executive ranks and was named CEO in 2008, followed by his appointment as chairman of the board the following year.
The article Eli Lilly CEO Returns to His Post originally appeared on Fool.com.Fool contributor Tim Brugger has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.